{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:01:27Z","timestamp":1789142487458,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006919","name":"Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006919","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"publisher","award":["U54-TR001012"],"award-info":[{"award-number":["U54-TR001012"]}],"id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["N01-CO-12400"],"award-info":[{"award-number":["N01-CO-12400"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI074687"],"award-info":[{"award-number":["AI074687"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 GM079662"],"award-info":[{"award-number":["R21 GM079662"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005303","name":"Boston College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005303","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.intimp.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T07:16:26Z","timestamp":1465802186000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes"],"prefix":"10.1016","volume":"38","author":[{"given":"Chenjia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene R.","family":"Wyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal A.","family":"Alaamery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon A.","family":"Argueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Douglas","family":"Ivey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia H.","family":"Burdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Chiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.06.004_bb0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2016.06.004_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2009.05124.x","article-title":"New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression","volume":"1183","author":"Steward-Tharp","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2016.06.004_bb0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Gavin","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2016.06.004_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","article-title":"Interleukin-2 receptor signaling: at the interface between tolerance and immunity","volume":"33","author":"Malek","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2016.06.004_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.immunol.20.091301.131133","article-title":"MAP kinases in the immune response","volume":"20","author":"Dong","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2016.06.004_bb0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1146\/annurev.bi.63.070194.005145","article-title":"Signal transmission between the plasma membrane and nucleus of T lymphocytes","volume":"63","author":"Crabtree","year":"1994","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.intimp.2016.06.004_bb0035","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2016.06.004_bb0040","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling","volume":"76","author":"Conti","year":"2007","journal-title":"Annu. Rev. Biochem."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2016.06.004_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BJ20051368","article-title":"Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies","volume":"393","author":"Lerner","year":"2006","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.intimp.2016.06.004_bb0050","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1073\/pnas.122041599","article-title":"Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses","volume":"99","author":"Jin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"27","key":"10.1016\/j.intimp.2016.06.004_bb0055","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2174\/092986706778773040","article-title":"Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD","volume":"13","author":"Huang","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2016.06.004_bb0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/bjp.2008.297","article-title":"Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking?","volume":"155","author":"Giembycz","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2016.06.004_bb0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current status","volume":"155","author":"Spina","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2016.06.004_bb0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1345\/aph.1Q646","article-title":"Roflumilast: a novel treatment for chronic obstructive pulmonary disease","volume":"46","author":"Reid","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.intimp.2016.06.004_bb0075","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1021\/jm900210d","article-title":"Discovery of (S)-N-[2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihy dro-1H-isoindol-4-yl] acetamide (apremilast), a potent and orally active phosphodiesterase 4 and tumor necrosis factor-alpha inhibitor","volume":"52","author":"Man","year":"2009","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2016.06.004_bb0080","first-page":"L279","article-title":"Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells","volume":"284","author":"Smith","year":"2003","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"5403","key":"10.1016\/j.intimp.2016.06.004_bb0085","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.283.5403.848","article-title":"CD3- and CD28-dependent induction of PDE7 required for T cell activation","volume":"283","author":"Li","year":"1999","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2016.06.004_bb0090","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1124\/mol.104.002246","article-title":"Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes","volume":"66","author":"Smith","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2016.06.004_bb0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1087057110362100","article-title":"New classes of PDE7 inhibitors identified by a fission yeast-based HTS","volume":"15","author":"Alaamery","year":"2010","journal-title":"J. Biomol. Screen."},{"issue":"1","key":"10.1016\/j.intimp.2016.06.004_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1087057107312127","article-title":"Development of a fission yeast-based high-throughput screen to identify chemical regulators of cAMP phosphodiesterases","volume":"13","author":"Ivey","year":"2008","journal-title":"J. Biomol. Screen."},{"issue":"35","key":"10.1016\/j.intimp.2016.06.004_bb0105","doi-asserted-by":"crossref","first-page":"30949","DOI":"10.1074\/jbc.M504398200","article-title":"Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7","volume":"280","author":"Wang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2016.06.004_bb0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chembiol.2011.12.010","article-title":"Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen","volume":"19","author":"Ceyhan","year":"2012","journal-title":"Chem. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2016.06.004_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"issue":"3","key":"10.1016\/j.intimp.2016.06.004_bb0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2014analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.intimp.2016.06.004_bb0125","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol."},{"issue":"20","key":"10.1016\/j.intimp.2016.06.004_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gni179","article-title":"Evolving gene\/transcript definitions significantly alter the interpretation of GeneChip data","volume":"33","author":"Dai","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.intimp.2016.06.004_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1198\/004017008000000334","article-title":"Quality assessment for short oligonucleotide microarray data","volume":"50","author":"Brettschneider","year":"2008","journal-title":"Technometrics"},{"issue":"1","key":"10.1016\/j.intimp.2016.06.004_bb0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"},{"issue":"8","key":"10.1016\/j.intimp.2016.06.004_bb0145","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1476-5381.1996.tb15629.x","article-title":"Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2","volume":"118","author":"Giembycz","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.06.004_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-642-17969-3_5","article-title":"A fission yeast-based platform for phosphodiesterase inhibitor HTSs and analyses of phosphodiesterase activity","volume":"204","author":"Demirbas","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.intimp.2016.06.004_bb0155","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1124\/mol.65.2.350","article-title":"Barbiturates directly inhibit the calcium\/calcineurin complex: a novel mechanism of inhibition of nuclear factor of activated T cells","volume":"65","author":"Humar","year":"2004","journal-title":"Mol. Pharm."},{"issue":"18","key":"10.1016\/j.intimp.2016.06.004_bb0160","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1073\/pnas.162359999","article-title":"Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors","volume":"99","author":"Riley","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.intimp.2016.06.004_bb0165","doi-asserted-by":"crossref","first-page":"11796","DOI":"10.1073\/pnas.092284399","article-title":"Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation","volume":"99","author":"Diehn","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2016.06.004_bb0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.intimp.2015.07.032","article-title":"Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function","volume":"28","author":"Blanco","year":"2015","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916302296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916302296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:49:05Z","timestamp":1778820545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916302296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"alternative-id":["S1567576916302296"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.06.004","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}